Human Molecular Genetics, 2002, Vol. 11, No. 18 2113-2118
© 2002 Oxford University Press
Homozygosity for a missense mutation in fibulin-5 (FBLN5) results in a severe form of cutis laxa
1Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium, 2Centre de Genetique Humaine, Institut de Pathologie et de Genetique, Loverval, Belgium, 3Department of Pediatrics, Sint-Lucas Hospital, Ghent, Belgium and 4Department of Dermatology, Ghent University Hospital, Ghent, Belgium
Received April 16, 2002; Revised June 20, 2002; Accepted June 24, 2002
Hereditary cutis laxa comprises a heterogeneous group of connective tissue disorders characterized by loose skin and variable systemic involvement. Autosomal dominant and recessive as well as X-linked forms have been described. Some dominant forms are caused by mutations in the elastine gene (ELN). The X-linked form is now classified in the group of copper transport diseases. The genetic defect underlying the autosomal recessive (AR) forms of cutis laxa is not known. The phenotypic abnormalities recently observed in a fibulin-5 knockout mouse model are reminiscent of human AR cutis laxa type I. Both share cutis laxa, lung emphysema and arterial involvement. Molecular study of the fibulin-5 (FBLN5) gene in a large consanguineous Turkish family with four patients affected by AR cutis laxa type I demonstrated the presence of a homozygous missense mutation (T998C) in the FBLN5 gene resulting in a serine-to-proline (S227P) substitution in the fourth calcium-binding epidermal growth factor-like domain of fibulin-5 protein. This amino acid substitution is predicted to have important structural and functional consequences for normal elastogenesis. As such, we provide evidence that a genetic defect in fibulin-5 (FBLN5, also known as EVEC or DANCE) is responsible for a recessive form of cutis laxa in humans.
* To whom correspondence should be addressed at: Ghent University Hospital, Department of Medical Genetics, De Pintelaan 185, B-9000 Ghent, Belgium. Tel: +32 92403602; Fax: +32 92404970; Email: anne.depaepe{at}rug.ac.be
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Horiguchi, T. Inoue, T. Ohbayashi, M. Hirai, K. Noda, L. Y. Marmorstein, D. Yabe, K. Takagi, T. O. Akama, T. Kita, et al. Fibulin-4 conducts proper elastogenesis via interaction with cross-linking enzyme lysyl oxidase PNAS, November 10, 2009; 106(45): 19029 - 19034. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. O. Jones, M.-C. Wang, T. A. Jowitt, C. Ridley, K. T. Mellody, M. Howard, T. Wang, P. N. Bishop, A. J. Lotery, C. M. Kielty, et al. Fibulin 5 Forms a Compact Dimer in Physiological Solutions J. Biol. Chem., September 18, 2009; 284(38): 25938 - 25943. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Hucthagowder, E. Morava, U. Kornak, D. J. Lefeber, B. Fischer, A. Dimopoulou, A. Aldinger, J. Choi, E. C. Davis, D. N. Abuelo, et al. Loss-of-function mutations in ATP6V0A2 impair vesicular trafficking, tropoelastin secretion and cell survival Hum. Mol. Genet., June 15, 2009; 18(12): 2149 - 2165. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jarvelainen, A. Sainio, M. Koulu, T. N. Wight, and R. Penttinen Extracellular Matrix Molecules: Potential Targets in Pharmacotherapy Pharmacol. Rev., June 1, 2009; 61(2): 198 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
S J Marciniak and D A Lomas What can naturally occurring mutations tell us about the pathogenesis of COPD? Thorax, April 1, 2009; 64(4): 359 - 364. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sisto, M. D'Amore, D. D. Lofrumento, P. Scagliusi, S. D'Amore, V. Mitolo, and S. Lisi Fibulin-6 expression and anoikis in human salivary gland epithelial cells: implications in Sjogren's syndrome Int. Immunol., March 1, 2009; 21(3): 303 - 311. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Lee, A. R. Albig, M. Regner, B. J. Schiemann, and W. P. Schiemann Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-{beta} in mammary epithelial cells via a MMP-dependent mechanism Carcinogenesis, December 1, 2008; 29(12): 2243 - 2251. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Van Maldergem, M. Yuksel-Apak, H. Kayserili, E. Seemanova, S. Giurgea, L. Basel-Vanagaite, E. Leao-Teles, J. Vigneron, M. Foulon, M. Greally, et al. Cobblestone-like brain dysgenesis and altered glycosylation in congenital cutis laxa, Debre type Neurology, November 11, 2008; 71(20): 1602 - 1608. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wachi, R. Nonaka, F. Sato, K. Shibata-Sato, M. Ishida, S. Iketani, I. Maeda, K. Okamoto, Z. Urban, S. Onoue, et al. Characterization of the Molecular Interaction between Tropoelastin and DANCE/Fibulin-5 J. Biochem., May 1, 2008; 143(5): 633 - 639. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. McLaughlin, B. Bakall, J. Choi, Z. Liu, T. Sasaki, E. C. Davis, A. D. Marmorstein, and L. Y. Marmorstein Lack of fibulin-3 causes early aging and herniation, but not macular degeneration in mice Hum. Mol. Genet., December 15, 2007; 16(24): 3059 - 3070. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. de Vega, T. Iwamoto, T. Nakamura, K. Hozumi, D. A. McKnight, L. W. Fisher, S. Fukumoto, and Y. Yamada TM14 Is a New Member of the Fibulin Family (Fibulin-7) That Interacts with Extracellular Matrix Molecules and Is Active for Cell Binding J. Biol. Chem., October 19, 2007; 282(42): 30878 - 30888. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Fu, D. Garland, Z. Yang, D. Shukla, A. Rajendran, E. Pearson, E. M. Stone, K. Zhang, and E. A. Pierce The R345W mutation in EFEMP1 is pathogenic and causes AMD-like deposits in mice Hum. Mol. Genet., October 15, 2007; 16(20): 2411 - 2422. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Y. Marmorstein, P. J. McLaughlin, N. S. Peachey, T. Sasaki, and A. D. Marmorstein Formation and progression of sub-retinal pigment epithelium deposits in Efemp1 mutation knock-in mice: a model for the early pathogenic course of macular degeneration Hum. Mol. Genet., October 15, 2007; 16(20): 2423 - 2432. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kobayashi, G. Kostka, J. H. O. Garbe, D. R. Keene, H. P. Bachinger, F.-G. Hanisch, D. Markova, T. Tsuda, R. Timpl, M.-L. Chu, et al. A Comparative Analysis of the Fibulin Protein Family: BIOCHEMICAL CHARACTERIZATION, BINDING INTERACTIONS, AND TISSUE LOCALIZATION J. Biol. Chem., April 20, 2007; 282(16): 11805 - 11816. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. El-Hallous, T. Sasaki, D. Hubmacher, M. Getie, K. Tiedemann, J. Brinckmann, B. Batge, E. C. Davis, and D. P. Reinhardt Fibrillin-1 Interactions with Fibulins Depend on the First Hybrid Domain and Provide an Adaptor Function to Tropoelastin J. Biol. Chem., March 23, 2007; 282(12): 8935 - 8946. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hanada, M. Vermeij, G. A. Garinis, M. C. de Waard, M. G.S. Kunen, L. Myers, A. Maas, D. J. Duncker, C. Meijers, H. C. Dietz, et al. Perturbations of Vascular Homeostasis and Aortic Valve Abnormalities in Fibulin-4 Deficient Mice Circ. Res., March 16, 2007; 100(5): 738 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zheng, E. C. Davis, J. A. Richardson, B. C. Starcher, T. Li, R. D. Gerard, and H. Yanagisawa Molecular Analysis of Fibulin-5 Function during De Novo Synthesis of Elastic Fibers Mol. Cell. Biol., February 1, 2007; 27(3): 1083 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Hu, B. L. Loeys, P. J. Coucke, A. De Paepe, R. P. Mecham, J. Choi, E. C. Davis, and Z. Urban Fibulin-5 mutations: mechanisms of impaired elastic fiber formation in recessive cutis laxa Hum. Mol. Genet., December 1, 2006; 15(23): 3379 - 3386. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-P. Kuang, M. Joyce-Brady, X.-H. Zhang, J.-C. Jean, and R. H. Goldstein Fibulin-5 gene expression in human lung fibroblasts is regulated by TGF-beta and phosphatidylinositol 3-kinase activity Am J Physiol Cell Physiol, December 1, 2006; 291(6): C1412 - C1421. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. McLaughlin, Q. Chen, M. Horiguchi, B. C. Starcher, J. B. Stanton, T. J. Broekelmann, A. D. Marmorstein, B. McKay, R. Mecham, T. Nakamura, et al. Targeted disruption of fibulin-4 abolishes elastogenesis and causes perinatal lethality in mice. Mol. Cell. Biol., March 1, 2006; 26(5): 1700 - 1709. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xiang, T. Sekine, H. Nakamura, S. Imajoh-Ohmi, H. Fukuda, K. Yudoh, K. Masuko-Hongo, K. Nishioka, and T. Kato Fibulin-4 is a target of autoimmunity predominantly in patients with osteoarthritis. J. Immunol., March 1, 2006; 176(5): 3196 - 3204. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Spencer, S. L. Hacker, E. C. Davis, R. P. Mecham, R. H. Knutsen, D. Y. Li, R. D. Gerard, J. A. Richardson, E. N. Olson, and H. Yanagisawa Altered vascular remodeling in fibulin-5-deficient mice reveals a role of fibulin-5 in smooth muscle cell proliferation and migration PNAS, February 22, 2005; 102(8): 2946 - 2951. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ramirez, L. Y. Sakai, H. C. Dietz, and D. B. Rifkin Fibrillin microfibrils: multipurpose extracellular networks in organismal physiology Physiol Genomics, October 4, 2004; 19(2): 151 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Rodriguez-Revenga, P. Iranzo, C. Badenas, S. Puig, A. Carrio, and M. Mila A Novel Elastin Gene Mutation Resulting in an Autosomal Dominant Form of Cutis Laxa Arch Dermatol, September 1, 2004; 140(9): 1135 - 1139. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Stone, T. A. Braun, S. R. Russell, M. H. Kuehn, A. J. Lotery, P. A. Moore, C. G. Eastman, T. L. Casavant, and V. C. Sheffield Missense Variations in the Fibulin 5 Gene and Age-Related Macular Degeneration N. Engl. J. Med., July 22, 2004; 351(4): 346 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Genevieve, C Baumann, C Huber, L Faivre, D Sanlaville, C Bodemer, S Hadj-Rabia, A Assoumou, A Verloes, F Raqbi, et al. A novel form of syndromic cutis laxa with facial dysmorphism, cleft palate, and mental retardation J. Med. Genet., June 1, 2004; 41(6): e77 - e77. [Full Text] [PDF] |
||||
![]() |
J. Blackburn, E. E. Tarttelin, C. Y. Gregory-Evans, M. Moosajee, and K. Gregory-Evans Transcriptional Regulation and Expression of the Dominant Drusen Gene FBLN3 (EFEMP1) in Mammalian Retina Invest. Ophthalmol. Vis. Sci., November 1, 2003; 44(11): 4613 - 4621. [Abstract] [Full Text] [PDF] |
||||

















